These results complement those from a previous report showing that MUC1 is a direct target for hsa-miR-145, and suppression of MUC1 is dependent on the 3′-UTR in metastatic breast cancer cell lines, demonstrated by luciferase reporter assays (65). The gene discussed is MUC1; the disease is breast carcinoma.